Administration order of midazolam/fentanyl for moderate dental sedation
- PMID: 29556559
- PMCID: PMC5858011
- DOI: 10.17245/jdapm.2018.18.1.47
Administration order of midazolam/fentanyl for moderate dental sedation
Abstract
Background: The purpose of this study is to investigate the effects of administration order when a sedative drug (midazolam) and an opioid analgesic drug (fentanyl) is applied for moderate intravenous (IV) sedation in dentistry.
Methods: A retrospective chart review was conducted in one dental clinic during its transition from a midazolam-first to a fentanyl-first protocol for dental procedures requiring moderate IV sedation. Physiological parameters, drug administration times, patient recovery times, drug dosages, and patient recall and satisfaction were investigated for differences.
Results: A total of 76 charts (40 midazolam-first and 36 fentanyl-first administrations), were used in the analysis. Administering midazolam first resulted in an average 4.38 min (52%) decrease in administration times (P < 0.001), and a decrease in procedural recollection immediately following the procedure (P = 0.03), and 24 to 48 hours later (P = 0.009). Administering fentanyl first required an average of 2.43 mg (29%) less midazolam (P < 0.001). No significant differences were found for change in vital signs, minimum oxygen saturation levels, recovery times, and patient satisfaction (P > 0.05). Oxygen saturation levels did not drop below 90% for either group; however, 5 cases in the fentanyl-first group fell to between 90% and 92%, compared with 0 cases in the midazolam-first group.
Conclusions: The administration order of fentanyl and midazolam may have different effects on patients and the sedation procedure. Findings from this study should be used to facilitate discussion among dental practitioners and to guide additional research investigating this topic.
Keywords: Conscious Sedation; Fentanyl; Midazolam; Moderate Sedation.
Conflict of interest statement
CONFLICT OF INTEREST AND SOURCES OF FUNDING: The authors state explicitly that there are no conflicts of interest in connection with this article.
Similar articles
-
Comparison of the effects of target-controlled infusion-remifentanil/midazolam and manual fentanyl/midazolam administration on patient parameters in dental procedures.J Dent Anesth Pain Med. 2022 Apr;22(2):117-128. doi: 10.17245/jdapm.2022.22.2.117. Epub 2022 Mar 25. J Dent Anesth Pain Med. 2022. PMID: 35449782 Free PMC article.
-
An outcome study comparing intravenous sedation with midazolam/fentanyl (conscious sedation) versus propofol infusion (deep sedation) for aesthetic surgery.Plast Reconstr Surg. 2003 Nov;112(6):1683-9; discussion 1690-1. doi: 10.1097/01.PRS.0000086363.34535.A4. Plast Reconstr Surg. 2003. PMID: 14578803
-
A comparison of fospropofol to midazolam for moderate sedation during outpatient dental procedures.Anesth Prog. 2013 Winter;60(4):162-77. doi: 10.2344/0003-3006-60.4.162. Anesth Prog. 2013. PMID: 24423419 Free PMC article. Clinical Trial.
-
Early cognitive impairment after sedation for colonoscopy: the effect of adding midazolam and/or fentanyl to propofol.Anesth Analg. 2009 Nov;109(5):1448-55. doi: 10.1213/ane.0b013e3181a6ad31. Epub 2009 Jul 17. Anesth Analg. 2009. PMID: 19617584 Clinical Trial.
-
Evaluating Sedation Strategies for Magnetic Resonance Imaging: A Comprehensive Review of Intravenous Fentanyl, Butorphanol, and Midazolam in Adult and Pediatric Populations.Cureus. 2024 Apr 19;16(4):e58593. doi: 10.7759/cureus.58593. eCollection 2024 Apr. Cureus. 2024. PMID: 38770500 Free PMC article. Review.
Cited by
-
Comparative Analysis of Intravenous Midazolam with Nasal Spray for Conscious Sedation in Minor Oral and Maxillofacial Surgeries.J Pharm Bioallied Sci. 2019 Feb;11(Suppl 1):S42-S50. doi: 10.4103/jpbs.JPBS_199_18. J Pharm Bioallied Sci. 2019. PMID: 30923430 Free PMC article.
-
Effectiveness and safety of dentist-led conscious sedation using fentanyl with midazolam in dentistry: a five-year retrospective service evaluation.Br Dent J. 2023 Jun 7:1-6. doi: 10.1038/s41415-023-5889-3. Online ahead of print. Br Dent J. 2023. PMID: 37286715 Free PMC article.
-
Ketamine as the main analgesic agent during analgesia-based sedation for elective colonoscopy - A randomised, double-blind, control study.Saudi J Anaesth. 2022 Oct-Dec;16(4):423-429. doi: 10.4103/sja.sja_488_22. Epub 2022 Sep 3. Saudi J Anaesth. 2022. PMID: 36337425 Free PMC article.
-
Comparison of the effects of target-controlled infusion-remifentanil/midazolam and manual fentanyl/midazolam administration on patient parameters in dental procedures.J Dent Anesth Pain Med. 2022 Apr;22(2):117-128. doi: 10.17245/jdapm.2022.22.2.117. Epub 2022 Mar 25. J Dent Anesth Pain Med. 2022. PMID: 35449782 Free PMC article.
References
-
- American Society of Anesthesiologists. Continuum of Depth of Sedation: Definition of General Anesthesia and Levels of Sedation/Analgesia 2014. [Available from: http://www.asahq.org/]
-
- Inverso G, Dodson TB, Gonzalez ML, Chuang SK. Complications of moderate sedation versus deep sedation/general anesthesia for adolescent patients undergoing third molar extraction. J Oral Maxillofac Surg. 2016;74:474–479. - PubMed
-
- Khader R, Oreadi D, Finkelman M, Jarmoc M, Chaudhary S, Schumann R, et al. A prospective randomized controlled trial of two different sedation sequences for third molar removal in adults. J Oral Maxillofac Surg. 2015;73:224–231. - PubMed
-
- Ong CK, Seymour RA, Tan JM. Sedation with midazolam leads to reduced pain after dental surgery. Anesth Analg. 2004;98:1289–1293. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources